Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer

NCT03559049 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Due to financial hardships suffered by the stakeholder

Conditions

Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Rucaparib

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]